Key Takeaways
- Meta shares declined approximately 1% to the $640 level during Monday’s early trading session, wiping out prior-day advances
- Chief Product Officer Christopher Cox liquidated 20,000 META shares valued at approximately $13 million on September 9
- Chief Operating Officer Javier Olivan and Chief Accounting Officer Aaron Anderson executed additional stock sales worth millions combined
- Both Wedbush and Oppenheimer analysts expressed measured optimism regarding Muse Agent’s monetization prospects
- Consensus rating across Wall Street remains Strong Buy for META, with analysts projecting an average target of $759.43, suggesting approximately 17% appreciation potential
Shares of Meta Platforms retreated approximately 1% to the $640 range during Monday’s pre-market session, erasing the 0.57% advance recorded in Friday’s trading.
The decline occurred after securities filings revealed that Christopher Cox, serving as Meta’s Chief Product Officer, executed a sale of 20,000 shares on September 9, generating proceeds of roughly $13 million. The stock dispositions occurred through a Rule 10b5-1 trading arrangement that Cox established in May 2026.
The executive divested 18,578 shares at a volume-weighted average price of $650.21, while an additional 1,422 shares were sold at $651.15. Following these transactions, Cox maintains ownership of 244,516 shares held through a revocable trust structure and an additional 55,046 shares via an irrevocable remainder trust.
Cox wasn’t the only senior executive reducing holdings. Chief Operating Officer Javier Olivan disposed of 5,354 shares generating approximately $3.3 million in proceeds, while Chief Accounting Officer Aaron Anderson sold 3,240 shares valued at roughly $2 million. Each of these dispositions was executed through previously established trading programs.
Notwithstanding this sequence of executive sales, TipRanks’ Insider Trading Activity monitoring system currently registers a Neutral outlook for Meta when evaluating recent insider transactions. Company insiders have simultaneously acquired approximately $2.3 million in stock throughout the previous three-month period.
Wedbush Maintains Hold Stance Following Muse Unveiling
The social media giant’s shares encountered additional headwinds after a pair of analysts refrained from elevating their recommendations despite Meta’s introduction of its innovative AI agent, Muse.
Wedbush’s Ygal Arounian preserved a Hold recommendation on META on September 11, though he increased his valuation target 9% upward from $595 to $650. This revised objective suggests minimal upside of just 0.30% from prevailing price levels.
Arounian characterized Muse as a substantive advancement in Meta’s artificial intelligence initiatives but emphasized that tangible financial returns remain uncertain. His ranking stands at #2,929 among 12,499 analysts monitored through TipRanks.
Oppenheimer Identifies Three Primary Obstacles for Muse
Jason Helfstein from Oppenheimer assigned a Buy rating while withholding a specific price objective, expressing uncertainty regarding Muse’s capacity to drive revenue for Meta.
Helfstein highlighted three particular challenges: questionable consumer appetite to pay for such services, intense rivalry from Google’s Gemini platform and OpenAI’s ChatGPT, and insufficient consumer confidence in entrusting Meta with sensitive credential information.
His assessment concluded that Muse Agent doesn’t represent “a game changer” for the technology giant.
Alternative perspectives exist among the analyst community. Evercore ISI reaffirmed its Outperform designation with an $860 valuation target. JPMorgan elevated META from Neutral to Overweight while increasing its target to $820, pointing to artificial intelligence advancements and innovations like Muse and Meta Model API accessibility. KeyBanc maintained its Overweight stance with a $780 objective.
The company additionally unveiled Muse Spark 1.3, which CEO Mark Zuckerberg characterized as the organization’s most substantial enhancement in programming and agentic functionality to date.
Throughout Wall Street, META commands a Strong Buy consensus derived from 38 Buy recommendations and 6 Hold ratings issued during the preceding three months. The mean price objective stands at $759.43, indicating approximately 17% upside potential from current trading levels.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
